Biomedical Company Avoids DOJ Prosecution After First Ever Voluntary Corporate Self-Disclosure of Fraud
ArentFox Schiff – On May 22, the US Department of Justice (DOJ) announced that it will not prosecute a Massachusetts biomedical company, DBA MilliporeSigma, for fraudulent conduct and conspiracy.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.